INTERLEUKIN-6 IS ELEVATED IN PLASMA IN MULTIPLE-SCLEROSIS

被引:0
|
作者
FREI, K
FREDRIKSON, S
FONTANA, A
LINK, H
机构
[1] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT NEUROL,S-14186 HUDDINGE,SWEDEN
[2] UNIV HOSP ZURICH,CLIN IMMUNOL SECT,CH-8091 ZURICH,SWITZERLAND
[3] UNIV HOSP ZURICH,DEPT NEUROSURG,CH-8091 ZURICH,SWITZERLAND
关键词
MULTIPLE SCLEROSIS; INTERLEUKIN-6; CEREBROSPINAL FLUID; MENINGITIS; B-CELL RESPONSE; AUTOIMMUNITY;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Levels of interleukin-6 (IL-6) - a cytokine which induces immunoglobulin production of activated B cells - were measured in cerebrospinal fluid (CSF) and plasma of patients with multiple sclerosis (MS), acute meningo-encephalitis (AM) and muscular tension headache (TH). MS patients had in repeated samples higher levels of IL-6 in plasma compared to patients with AM and TH. IL-6 concentrations in MS plasma were about 17 times higher than MS CSF, while in AM 20-fold higher levels were found in CSF compared to plasma during the acute stage. IL-6 in AM CSF decreased rapidly during clinical recovery. No correlation was found between IL-6 in MS patients' plasma or CSF and disease activity. The functional significance of elevated IL-6 concentrations in MS plasma is unknown, although the findings support the hypothesis of a systemic B cell response in MS.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [1] Interleukin-6 expression in human multiple sclerosis lesions
    Schönrock, LM
    Gawlowski, G
    Brück, W
    NEUROSCIENCE LETTERS, 2000, 294 (01) : 45 - 48
  • [2] Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis
    Navikas, V
    Matusevicius, D
    Soderstrom, M
    Fredrikson, S
    Kivisakk, P
    Ljungdahl, A
    Hojeberg, B
    Link, H
    JOURNAL OF NEUROIMMUNOLOGY, 1996, 64 (01) : 63 - 69
  • [3] Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
    Uzawa, Akiyuki
    Mori, Masahiro
    Ito, Michihiro
    Uchida, Tomohiko
    Hayakawa, Sei
    Masuda, Saeko
    Kuwabara, Satoshi
    JOURNAL OF NEUROLOGY, 2009, 256 (12) : 2082 - 2084
  • [4] Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
    Akiyuki Uzawa
    Masahiro Mori
    Michihiro Ito
    Tomohiko Uchida
    Sei Hayakawa
    Saeko Masuda
    Satoshi Kuwabara
    Journal of Neurology, 2009, 256 : 2082 - 2084
  • [5] Serum level of interleukin-6 in Chinese patients with multiple sclerosis
    Chen, Ying-Chun
    Yang, Xin
    Miao, Ling
    Liu, Zhen-Guo
    Li, Wei
    Zhao, Zhong-Xin
    Sun, Xiao-Jiang
    Jiang, Guo-Xin
    Chen, Sheng-Di
    Cheng, Qi
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 249 (1-2) : 109 - 111
  • [6] Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis
    Itorralba, Justine
    Brand-Arzamendi, Koroboshka
    Saab, Georges
    Muccilli, Alexandra
    Schneider, Raphael
    BMC NEUROLOGY, 2025, 25 (01)
  • [7] Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients
    Miljkovic, D
    Drulovic, J
    Trajkovic, V
    Mesaros, S
    Dujmovic, I
    Maksimovic, D
    Samardzic, T
    Stojsavljevic, N
    Levic, Z
    Stojkovic, MM
    EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (04) : 413 - 418
  • [8] Elevated interleukin-6 in schizophrenia
    van Kammen, DP
    McAllister-Sistilli, CG
    Kelley, ME
    Gurklis, JA
    Yao, JK
    PSYCHIATRY RESEARCH, 1999, 87 (2-3) : 129 - 136
  • [9] Increased T-lymphocyte interleukin-6 binding in patients with multiple sclerosis
    Bongioanni, P
    Mosti, S
    Romano, MR
    Lombardo, F
    Moscato, G
    Meucci, G
    EUROPEAN JOURNAL OF NEUROLOGY, 2000, 7 (03) : 291 - 297
  • [10] CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis
    Padberg, F
    Feneberg, W
    Schmidt, S
    Schwarz, MJ
    Körschenhausen, D
    Greenberg, BD
    Nolde, T
    Müller, N
    Trapmann, H
    König, N
    Möller, HJ
    Hampel, H
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 99 (02) : 218 - 223